Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases

Written By Yolandi Stanek

PALO ALTO, Calif. and DURHAM, N.C., June 04, 2021 /PRNewswire/ -- Auransa, Inc., an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (POLARISqb), a quantum drug design company, announced a research collaboration addressing therapeutics for neglected diseases disproportionately affecting women.

Yolandi Stanek https://helloyo.com
Previous

POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI
Next

AU-409: a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma